Scott Cameron, MD, PhD

Appointed
2019

Education & Fellowships

Fellowship - Strong Memorial Hospital of The University of Rochester
Cardiovascular Disease
Rochester, NY
2016

Residency - New York Presbyterian Hospital
Medicine
New York, NY
2011

Medical Education - State University of New York (SUNY) Upstate Medical University
Medicine
Syracuse, NY
2009

Fellowship - Johns Hopkins Hospital
Chemical Pathology
Baltimore, MD United States
2005

Graduate School - University of Rochester Medical Center
Pharmacology
Rochester, NY
2003

Undergraduate - University of Edinburgh
Edinburgh,
1998

Additional Training

• Clinical Chemistry (Chemical Pathology)

Professional Highlights

• Founding Member and Director, University of Rochester Pulmonary Embolism Response Team: Award from the Hospital Board on Quality and Safety in Patient Care.

Certifications

• Registered Physician in Vascular Interpretation
• Vascular Medicine
• Internal Medicine
• Internal Medicine - Cardiovascular Disease

Specialty Interests

Abdominal Aortic Aneurysms, Carotid Disease, Coronary Artery Disease, Deep vein thrombosis, Pulmonary Embolism, Platelet Disorders

Awards & Honors

• 2022 Gill Heart and Vascular Institute Early Career Gill Award
• 2019 Outstanding Young Alumnus Award, Upstate Medical University
• 2017 Quality and Safety Certificate - Pulmonary Embolism Response Team
• 2016 Fellow of the American College of Cardiology
• 2016 Fellow of the Society of Vascular Medicine
• 2015 Platelet Colloquium Career Investigator Award, University of Kentucky
• 2014 CVRI Scientific Advisory Board Postdoctoral Research Award (first place)
• 2012 Multiple “Strong Star” nominations from patients and colleagues for exceptional clinical care
• 2009 Alpha Omega Alpha Research Award 
• 2009 Herbert Lourie, MD Graduation Award
• 2008 Gold Humanism Honor Society
• 2005 Paul E. Standjord Young Investigator’s Award - with distinction
• 2005 Pathology Young Investigator’s Award for excellence in basic research
• 2004 Pathology Young Investigator’s Award for excellence in clinical research
• 2003 Dean's Award for the most innovative PhD Thesis

Innovations & Patents

Memberships

• Fellow, American College of Cardiology
• Fellow, Society of Vascular Medicine
• Member, American Heart Association

See publications for Scott Cameron, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/2/2025, Dr. Cameron has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Cameron receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Sanofi US Services Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.